ada.enesco, Author at European Medical Journal - Page 2 of 65

New Blood Marker Predicts Future Asthma Attacks

Sphingolipid-to-steroid ratios in blood accurately predict asthma attacks years in advance, offering a new precision medicine tool for asthma care.

Shingles Vaccine May Slow Biological Ageing

New research suggests shingles vaccination may slow biological ageing and reduce inflammation, supporting healthier ageing beyond infection prevention.

ctDNA Levels Predict Treatment Response in Breast Cancer

Low baseline ctDNA and early clearance during treatment are strongly associated with improved response and survival in advanced breast cancer, highlighting ctDNA as a promising predictive and surrogate biomarker.

Gut Microbiota Linked to Long-Term Pancreatitis Outcomes

Early gut microbiota changes may predict diabetes, recurrence, and mortality after acute pancreatitis, offering new tools for long-term risk assessment.

Blood Test May Detect Liver Cancer at Earlier Stage

New research suggests a blood-based test could improve early detection of liver cancer in high-risk patients.

New Report Shows Progress and Gaps in Global Hepatitis Elimination

A new global report shows uneven progress towards viral hepatitis elimination, with major gaps in diagnosis and treatment contributing to ongoing liver-related deaths.

3D Cardiac Mapping Improves Arrhythmia Detection

Volumetric non-invasive cardiac mapping reduced geodesic localisation error by 59.3% compared with surface-only approaches, demonstrating substantially improved accuracy in identifying arrhythmia origins.

New Data Highlight Gaps in Preconception Health Support for Women

New data show that many women lack access to preconception health advice, highlighting missed opportunities to improve reproductive and pregnancy outcomes.

Real-World Data Support Lebrikizumab Effectiveness in Atopic Dermatitis

Real-world data suggest lebrikizumab delivers sustained clinical and quality-of-life improvements in patients with moderate-to-severe atopic dermatitis.

UK Trial to Screen 42,000 Patients for Early Liver Disease

A major UK trial launched to screen up to 42,000 adults in primary care for early liver disease using non-invasive testing.